We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+21.28%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$2.3B
AUM Growth
+$384M
Cap. Flow
+$216M
Cap. Flow %
9.39%
Top 10 Hldgs %
49.4%
Holding
255
New
116
Increased
33
Reduced
43
Closed
21

Top Buys

Rank Stock Value
1
KSPI icon
Kaspi.kz JSC
KSPI
+$20M
2
MREO
Mereo BioPharma
MREO
+$19.3M
3
BDX icon
Becton Dickinson
BDX
+$17.1M
4
SUNC
SunocoCorp LLC
SUNC
+$11.8M
5
MOH icon
Molina Healthcare
MOH
+$8.88M

Top Sells

Rank Stock Value
1
WDC icon
Western Digital
WDC
+$29.7M
2
QURE icon
uniQure
QURE
+$26.4M
3
LLY icon
Eli Lilly
LLY
+$21.8M
4
BBIO icon
BridgeBio Pharma
BBIO
+$19.6M
5
SNDK
Sandisk
SNDK
+$16.4M

Sector Composition

Rank Sector Weight
1 Healthcare 21.71%
2 Financials 6.94%
3 Consumer Discretionary 6.7%
4 Industrials 3.7%
5 Technology 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LULU icon
76
PUT
lululemon athletica
LULU
$14B
$5.2M 0.23%
25,000
– –
LEN icon
77
PUT
Lennar Class A
LEN
$21.2B
$5.14M 0.22%
50,000
– –
RARE icon
78
Ultragenyx Pharmaceutical
RARE
$2.46B
$5.12M 0.22%
222,395
+116,395
+110% +$3.83M
STTK icon
79
Shattuck Labs
STTK
$704M
$5.07M 0.22%
1,390,000
-142,216
-9% -$339K
RNAM
80
DELISTED
Avidity Biosciences
RNAM
$5.05M 0.22%
+70,000
New +$4.52M
MBX
81
PUT
MBX Biosciences
MBX
$3.21B
$5.01M 0.22%
158,800
-125,000
-44% -$3.03M
SAIC icon
82
Saic
SAIC
$5.09B
$4.93M 0.21%
49,000
-3,500
-7% -$334K
VKTX icon
83
CALL
Viking Therapeutics
VKTX
$3.91B
$4.8M 0.21%
136,500
+36,500
+37% +$1.29M
ENVA icon
84
Enova International
ENVA
$6.55B
$4.72M 0.21%
+30,000
New +$3.9M
RXO icon
85
RXO
RXO
$3.46B
$4.52M 0.2%
+357,953
New +$5.28M
PTGX icon
86
CALL
Protagonist Therapeutics
PTGX
$8.83B
$4.39M 0.19%
+50,300
New +$4.12M
DDI
87
DoubleDown Interactive
DDI
$591M
$4.32M 0.19%
500,000
+200,000
+67% +$1.79M
STGW icon
88
Stagwell
STGW
$2.16B
$4.06M 0.18%
830,000
-60,000
-7% -$312K
ABEO icon
89
Abeona Therapeutics
ABEO
$388M
$4.06M 0.18%
770,000
– –
BLDR icon
90
Builders FirstSource
BLDR
$8.16B
$3.7M 0.16%
36,000
– –
COIN icon
91
Coinbase
COIN
$39.5B
$3.55M 0.15%
15,700
+12,700
+423% +$3.78M
PANL icon
92
Pangaea Logistics
PANL
$474M
$3.41M 0.15%
495,000
-40,000
-7% -$242K
MLTX icon
93
PUT
MoonLake Immunotherapeutics
MLTX
$1.49B
$3.37M 0.15%
+255,400
New +$3.01M
IFRX icon
94
InflaRx
IFRX
$261M
$3.35M 0.15%
3,315,000
+1,065,000
+47% +$1.32M
NVGS icon
95
Navigator Holdings
NVGS
$1.27B
$3.22M 0.14%
186,000
+6,000
+3% +$100K
BNED icon
96
Barnes & Noble Education
BNED
$439M
$3.22M 0.14%
350,000
– –
HHH icon
97
Howard Hughes
HHH
$3.92B
$3.03M 0.13%
38,000
– –
IRS
98
IRSA Inversiones y Representaciones
IRS
$1.26B
$2.56M 0.11%
155,000
-179,179
-54% -$2.57M
LAFA
99
LaFayette Acquisition Corp
LAFA
$159M
$2.48M 0.11%
+250,000
New +$2.47M
TMDX icon
100
PUT
Transmedics
TMDX
$2.64B
$2.43M 0.11%
20,000
– –
2 3
4
5 6

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, 683 Capital Management held 255 positions worth $2.3B, up 20% from $1.91B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

683 Capital Management deployed $216M of net new capital in Q4 2025, opening 116 new positions and adding to 33 existing holdings. Its largest new stake was Kaspi.kz JSC: 265,000 shares worth $20.7M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Western Digital, an estimated $29.7M trimmed.

  • 683 Capital Management's largest Q4 2025 buy was Kaspi.kz JSC: 265,000 shares worth $20.7M.
  • 683 Capital Management added most to Mereo BioPharma in Q4 2025, an estimated $19.3M increase.
  • 683 Capital Management's biggest Q4 2025 reduction was Western Digital, cutting an estimated $29.7M.
  • 683 Capital Management fully exited Eli Lilly in Q4 2025, selling an estimated $21.8M.
  • 683 Capital Management's ten largest holdings make up 49% of its $2.3B portfolio in Q4 2025.
  • 683 Capital Management opened 116 new positions and closed 21 in Q4 2025.
  • 683 Capital Management's portfolio value rose 20% quarter-over-quarter to $2.3B.

Based on 683 Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.